- Page 1 and 2: Neuropsychiatric Symptoms of Neurol
- Page 3 and 4: Health care professionals are start
- Page 5 and 6: Editor Marco Mula Atkinson Morley R
- Page 7 and 8: vi Preface symptoms in patients wit
- Page 9 and 10: viii Foreword I who have an interes
- Page 11: x Foreword II sion, it is hardly su
- Page 15 and 16: xiv Contents 12 Neuropsychiatric Sy
- Page 17 and 18: xvi Contributors Institute of Medic
- Page 19 and 20: Chapter 1 Neurobehavioral Comorbidi
- Page 21 and 22: 1 Neurobehavioral Comorbidities of
- Page 23 and 24: 1 Neurobehavioral Comorbidities of
- Page 25 and 26: 1 Neurobehavioral Comorbidities of
- Page 27 and 28: 1 Neurobehavioral Comorbidities of
- Page 29 and 30: 1 Neurobehavioral Comorbidities of
- Page 31 and 32: 1 Neurobehavioral Comorbidities of
- Page 33 and 34: 1 Neurobehavioral Comorbidities of
- Page 35 and 36: 1 Neurobehavioral Comorbidities of
- Page 37 and 38: 1 Neurobehavioral Comorbidities of
- Page 39 and 40: 1 Neurobehavioral Comorbidities of
- Page 41 and 42: 1 Neurobehavioral Comorbidities of
- Page 43 and 44: Chapter 2 Depression Andres M. Kann
- Page 45 and 46: 2 Depression 27 developing unprovok
- Page 47 and 48: 2 Depression 29 atypical clinical m
- Page 49 and 50: 2 Depression 31 are more likely to
- Page 51 and 52: 2 Depression 33 ral lobectomy. For
- Page 53 and 54: 2 Depression 35 ticularly in PWE at
- Page 55 and 56: 2 Depression 37 Other Types of Psyc
- Page 57 and 58: 2 Depression 39 31. Mendez MF, Cumm
- Page 59 and 60: 2 Depression 41 76. Grimsley SR, Ja
- Page 61 and 62: 44 M. Mula direction the malady tak
- Page 63 and 64:
46 M. Mula Table 3.1 Manic symptoms
- Page 65 and 66:
48 M. Mula In patients with epileps
- Page 67 and 68:
50 M. Mula 9. Sedler MJ. Falret’s
- Page 69 and 70:
Chapter 4 Anxiety Christian Brandt
- Page 71 and 72:
4 Anxiety 55 Ictal anxiety is frequ
- Page 73 and 74:
4 Anxiety 57 a current history of d
- Page 75 and 76:
4 Anxiety 59 seizures to irrelevant
- Page 77 and 78:
4 Anxiety 61 Alternative Treatments
- Page 79 and 80:
4 Anxiety 63 1. Kanner AM. Anxiety
- Page 81 and 82:
4 Anxiety 65 30. Gandy M, Sharpe L,
- Page 83 and 84:
4 Anxiety 67 72. Hamilton KT, Ander
- Page 85 and 86:
70 N. Adachi and N. Akanuma Introdu
- Page 87 and 88:
72 N. Adachi and N. Akanuma combina
- Page 89 and 90:
74 N. Adachi and N. Akanuma Delusio
- Page 91 and 92:
76 N. Adachi and N. Akanuma Post-ic
- Page 93 and 94:
78 N. Adachi and N. Akanuma to the
- Page 95 and 96:
80 N. Adachi and N. Akanuma Table 5
- Page 97 and 98:
82 N. Adachi and N. Akanuma Ictal P
- Page 99 and 100:
84 N. Adachi and N. Akanuma [ 61 ],
- Page 101 and 102:
86 N. Adachi and N. Akanuma 18. Tri
- Page 103 and 104:
88 N. Adachi and N. Akanuma 67. Kan
- Page 105 and 106:
Chapter 6 Obsessiveness and Viscosi
- Page 107 and 108:
6 Obsessiveness and Viscosity 93 re
- Page 109 and 110:
6 Obsessiveness and Viscosity 95 re
- Page 111 and 112:
6 Obsessiveness and Viscosity 97 re
- Page 113 and 114:
100 H.Y. Elnazer and N. Agrawal whi
- Page 115 and 116:
102 H.Y. Elnazer and N. Agrawal Dep
- Page 117 and 118:
104 H.Y. Elnazer and N. Agrawal wit
- Page 119 and 120:
106 H.Y. Elnazer and N. Agrawal con
- Page 121 and 122:
108 H.Y. Elnazer and N. Agrawal or
- Page 123 and 124:
110 H.Y. Elnazer and N. Agrawal beh
- Page 125 and 126:
112 H.Y. Elnazer and N. Agrawal Ref
- Page 127 and 128:
114 H.Y. Elnazer and N. Agrawal 49.
- Page 129 and 130:
116 H.Y. Elnazer and N. Agrawal 93.
- Page 131 and 132:
118 P. Tinuper et al. patients with
- Page 133 and 134:
120 P. Tinuper et al. intense distr
- Page 135 and 136:
122 P. Tinuper et al. Confusional a
- Page 137 and 138:
124 P. Tinuper et al. clinical pict
- Page 139 and 140:
126 P. Tinuper et al. tem atrophy (
- Page 141 and 142:
128 P. Tinuper et al. Sleep bruxism
- Page 143 and 144:
130 P. Tinuper et al. hypnagogic dr
- Page 145 and 146:
132 P. Tinuper et al. been postulat
- Page 147 and 148:
134 P. Tinuper et al. rupted [ 86 ]
- Page 149 and 150:
136 P. Tinuper et al. 26. Manni R,
- Page 151 and 152:
138 P. Tinuper et al. 73. Resnick T
- Page 153 and 154:
Chapter 9 Dissociation Matthias Sch
- Page 155 and 156:
9 Dissociation 143 neurological or
- Page 157 and 158:
9 Dissociation 145 of posttraumatic
- Page 159 and 160:
9 Dissociation 147 Table 9.1 Non-ep
- Page 161 and 162:
9 Dissociation 149 tentative treatm
- Page 163 and 164:
9 Dissociation 151 reported. The is
- Page 165 and 166:
9 Dissociation 153 they do not expr
- Page 167 and 168:
9 Dissociation 155 providing most h
- Page 169 and 170:
9 Dissociation 157 Outcome and Prog
- Page 171 and 172:
9 Dissociation 159 25. Holmes EA, B
- Page 173 and 174:
9 Dissociation 161 70. Thompson N,
- Page 175 and 176:
164 A.E. Cavanna No better neurolog
- Page 177 and 178:
166 A.E. Cavanna Over the last few
- Page 179 and 180:
168 A.E. Cavanna performance. Level
- Page 181 and 182:
170 A.E. Cavanna level of conscious
- Page 183 and 184:
172 A.E. Cavanna The development of
- Page 185 and 186:
174 A.E. Cavanna 14. Cavanna AE, Mu
- Page 187 and 188:
176 A.E. Cavanna 65. Di Perri C, St
- Page 189 and 190:
178 S. Meletti Introduction Emotion
- Page 191 and 192:
180 S. Meletti Recognition of Emoti
- Page 193 and 194:
182 S. Meletti Emotion Recognition
- Page 195 and 196:
184 S. Meletti a 100 90 % correct r
- Page 197 and 198:
186 S. Meletti Beyond side matters,
- Page 199 and 200:
188 S. Meletti epilepsy or not. Thi
- Page 201 and 202:
190 S. Meletti References 1. Darwin
- Page 203 and 204:
192 S. Meletti 47. Brierley B, Medf
- Page 205 and 206:
Chapter 12 Neuropsychiatric Symptom
- Page 207 and 208:
12 Neuropsychiatric Symptoms in Lea
- Page 209 and 210:
12 Neuropsychiatric Symptoms in Lea
- Page 211 and 212:
12 Neuropsychiatric Symptoms in Lea
- Page 213 and 214:
12 Neuropsychiatric Symptoms in Lea
- Page 215 and 216:
12 Neuropsychiatric Symptoms in Lea
- Page 217 and 218:
12 Neuropsychiatric Symptoms in Lea
- Page 219 and 220:
12 Neuropsychiatric Symptoms in Lea
- Page 221 and 222:
12 Neuropsychiatric Symptoms in Lea
- Page 223 and 224:
Chapter 13 Attention, Executive Fun
- Page 225 and 226:
13 Attention, Executive Function, a
- Page 227 and 228:
13 Attention, Executive Function, a
- Page 229 and 230:
13 Attention, Executive Function, a
- Page 231 and 232:
13 Attention, Executive Function, a
- Page 233 and 234:
13 Attention, Executive Function, a
- Page 235 and 236:
13 Attention, Executive Function, a
- Page 237 and 238:
13 Attention, Executive Function, a
- Page 239 and 240:
13 Attention, Executive Function, a
- Page 241 and 242:
13 Attention, Executive Function, a
- Page 243 and 244:
13 Attention, Executive Function, a
- Page 245 and 246:
Chapter 14 Dementia Alla Guekht Abs
- Page 247 and 248:
14 Dementia 237 investigations that
- Page 249 and 250:
14 Dementia 239 An age- accelerated
- Page 251 and 252:
14 Dementia 241 Dementia phenotypes
- Page 253 and 254:
14 Dementia 243 Treatment Comorbidi
- Page 255 and 256:
14 Dementia 245 CBZ, PHT, PB may be
- Page 257 and 258:
14 Dementia 247 32. Hussain SA, Hau
- Page 259 and 260:
14 Dementia 249 72. Golarai G, Gree
- Page 261 and 262:
14 Dementia 251 108. Koeller HB, Ro
- Page 263 and 264:
14 Dementia 253 145. Ford AH, Flick
- Page 265 and 266:
Chapter 15 Stress and Epilepsy Clar
- Page 267 and 268:
15 Stress and Epilepsy 257 intruder
- Page 269 and 270:
15 Stress and Epilepsy 259 Table 15
- Page 271 and 272:
15 Stress and Epilepsy 261 adherenc
- Page 273 and 274:
15 Stress and Epilepsy 263 environm
- Page 275 and 276:
15 Stress and Epilepsy 265 a b
- Page 277 and 278:
15 Stress and Epilepsy 267 when it
- Page 279 and 280:
15 Stress and Epilepsy 269 a Normal
- Page 281 and 282:
15 Stress and Epilepsy 271 that dec
- Page 283 and 284:
15 Stress and Epilepsy 273 Associat
- Page 285 and 286:
15 Stress and Epilepsy 275 Table 15
- Page 287 and 288:
15 Stress and Epilepsy 277 [ 134 ]
- Page 289 and 290:
15 Stress and Epilepsy 279 Vagal Ne
- Page 291 and 292:
15 Stress and Epilepsy 281 Referenc
- Page 293 and 294:
15 Stress and Epilepsy 283 48. Robe
- Page 295 and 296:
15 Stress and Epilepsy 285 90. Lai
- Page 297 and 298:
15 Stress and Epilepsy 287 130. Cha
- Page 299 and 300:
290 M. Beghi et al. Table 16.1 Age-
- Page 301 and 302:
292 M. Beghi et al. Depression itse
- Page 303 and 304:
294 M. Beghi et al. between drug ex
- Page 305 and 306:
296 M. Beghi et al. Table 16.3 Risk
- Page 307 and 308:
298 M. Beghi et al. SSRI overdose c
- Page 309 and 310:
300 M. Beghi et al. Conclusion In l
- Page 311 and 312:
302 M. Beghi et al. 37. Isbister GK
- Page 313 and 314:
304 G. Rayner and S.J. Wilson Keywo
- Page 315 and 316:
306 G. Rayner and S.J. Wilson Table
- Page 317 and 318:
308 G. Rayner and S.J. Wilson Table
- Page 319 and 320:
310 G. Rayner and S.J. Wilson anxie
- Page 321 and 322:
312 G. Rayner and S.J. Wilson conte
- Page 323 and 324:
314 G. Rayner and S.J. Wilson disor
- Page 325 and 326:
316 G. Rayner and S.J. Wilson becam
- Page 327 and 328:
318 G. Rayner and S.J. Wilson Rare
- Page 329 and 330:
320 G. Rayner and S.J. Wilson In th
- Page 331 and 332:
322 G. Rayner and S.J. Wilson Posts
- Page 333 and 334:
324 G. Rayner and S.J. Wilson compl
- Page 335 and 336:
326 G. Rayner and S.J. Wilson delin
- Page 337 and 338:
328 G. Rayner and S.J. Wilson 31. B
- Page 339 and 340:
330 G. Rayner and S.J. Wilson 74. M
- Page 341 and 342:
332 G. Rayner and S.J. Wilson 119.
- Page 343 and 344:
334 M. Yogarajah and M. Mula HRSA L
- Page 345 and 346:
336 M. Yogarajah and M. Mula group
- Page 347 and 348:
338 M. Yogarajah and M. Mula Ethosu
- Page 349 and 350:
340 M. Yogarajah and M. Mula Depres
- Page 351 and 352:
342 M. Yogarajah and M. Mula Two he
- Page 353 and 354:
344 M. Yogarajah and M. Mula normal
- Page 355 and 356:
346 M. Yogarajah and M. Mula Other
- Page 357 and 358:
348 M. Yogarajah and M. Mula as wel
- Page 359 and 360:
350 M. Yogarajah and M. Mula At the
- Page 361 and 362:
352 M. Yogarajah and M. Mula 8. Whi
- Page 363 and 364:
354 M. Yogarajah and M. Mula 53. Te
- Page 365 and 366:
356 M. Yogarajah and M. Mula 98. Ok
- Page 367 and 368:
358 M. Yogarajah and M. Mula 144. M
- Page 369 and 370:
360 M. Yogarajah and M. Mula 184. L
- Page 371 and 372:
362 S.C. Schachter techniques. Whil
- Page 373 and 374:
364 S.C. Schachter of controls; and
- Page 375 and 376:
366 S.C. Schachter patients 18 year
- Page 377 and 378:
368 S.C. Schachter of nightly (appr
- Page 379 and 380:
370 S.C. Schachter than sham [ 99 ]
- Page 381 and 382:
372 S.C. Schachter Limitations of C
- Page 383 and 384:
374 S.C. Schachter 25. Mattsson P,
- Page 385 and 386:
376 S.C. Schachter 69. Nahas Z, Mar
- Page 387:
378 S.C. Schachter 108. Fisher R, S